Position in GLAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$332,150
New position
Shares Held
25,550
first reported quarter
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 53 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 97%
Shared 3%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $67,490,391 across 30 Drug Manufacturers - Specialty & Generic names. GLAS ranks #20 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
123,778 | $20,861,543 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
20,210 | $10,950,383 | |
| 3 | ZTS |
Zoetis Inc.
|
90,284 | $6,487,806 | |
| 4 | VTRS |
Viatris Inc
|
280,668 | $4,457,007 | |
| 5 | HLN |
Haleon plc
|
443,467 | $4,137,546 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
106,508 | $3,608,490 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
184,772 | $2,677,345 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
40,488 | $2,589,207 |
All Filings in GLAS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $332,150 | 25,550 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||